Clinical trials
Active, not recruiting Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
225 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 10 |
| 2021 | 12 |
| 2022 | 15 |
| 2023 | 29 |
| 2024 | 26 |
| 2025 | 72 |
| 2026 | 42 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 225 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 20 |
| University of Colorado, Denver | 8 |
| Amgen | 6 |
| Novo Nordisk A/S | 5 |
| Pfizer | 5 |
| Hoffmann-La Roche | 4 |
| AstraZeneca | 3 |
| Dong Peng | 3 |
| First Affiliated Hospital of Chongqing Medical University | 3 |
| Kailera | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 225 |
| Obesity | 205 |
| Diabetes Mellitus, Type 2 | 26 |
| Weight Loss | 21 |
| Hypertension | 18 |
| Diabetes Mellitus | 16 |
| Insulin Resistance | 12 |
| Body Weight | 10 |
| Cardiovascular Diseases | 10 |
| Prediabetic State | 10 |
Trials
Showing 1 to 25 of 225. Each trial links to its page on Pharma Observatory.
125 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.